Ozempic can help people with diabetes walk better despite poor blood flow to legs: Why Lancet study is significant
Semaglutide, the diabetes and weight loss drug that’s commonly known as Ozempic, can help patients of peripheral artery ...
Gene therapy for blood cancer shows 73 per cent response rate in clinical trials: Lancet study
A new study published in The Lancet Haematology journal says that an indigenously developed gene therapy for certain blood ...